Millennium Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Millennium Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-402,509	Closed	-$21.7M	–	4355
2017 Q4	$21.7M	Sell	402,509 -62,921	-14%	-$3.44M	0.03%	851
2017 Q3	$26.6M	Buy	465,430 +449,470	+2,816%	+$26.3M	0.04%	637
2017 Q2	$960K	Sell	15,960 -1,730,529	-99%	-$98.5M	﹤0.01%	2465
2017 Q1	$95.1M	Buy	+1,746,489	New	+$86M	0.17%	136

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Millennium Management's BIVV Position: Q1 2018 in Review

Millennium Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 402,509 shares — an estimated $21.7M sold.

Millennium Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $95.1M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Millennium Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Millennium Management sold 402,509 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $21.7M.
Millennium Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Millennium Management's Bioverativ Inc. Common Stock position peaked at $95.1M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.